Nils Henrik Milton Rammer

Chordate Medical Holding AB

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (3 ops.)

€51k

▼ Sales (2 ops.)

€56k

Latest filing published 26 Dec 2024 for Chordate Medical Holding AB, €3,473. Read the official filing

Filing timeline

BuySale

Nils Henrik Milton Rammer

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Chordate Medical Holding AB 3 purchases · last 27 Dec 2024

Nils Henrik Milton Rammer: trading record in brief

Nils Henrik Milton Rammer appears in our data through filings on Chordate Medical Holding AB shares, published by Finansinspektionen. In total, 11 filings cover trades dated from 15 June 2018 to 23 December 2024.

The open-market side counts 3 purchases for €51k alongside 2 sales for €56k. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. So far in 2024, the count stands at 1 purchase and 1 sale.

On 27 December 2024 came the latest disclosure, an open-market purchase for €3,473 in Chordate Medical Holding AB. The median gap between a trade and its publication by Finansinspektionen is 4 days. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.